Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.
<h4>Background</h4>To accelerate the progress towards onchocerciasis elimination, a macrofilaricidal drug that kills the adult parasite is urgently needed. Emodepside has shown macrofilaricidal activity against a variety of nematodes and is currently under clinical development for the tr...
Main Authors: | Frauke Assmus, Richard M Hoglund, Frédéric Monnot, Sabine Specht, Ivan Scandale, Joel Tarning |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-03-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0010219 |
Similar Items
-
Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside
by: Frauke Assmus, et al.
Published: (2022-03-01) -
Drug development for the treatment of onchocerciasis: population pharmacokinetic and adverse events modeling of emodepside
by: Assmus, F, et al.
Published: (2022) -
Potential of emodepside for vector-borne disease control
by: Pattarapon Khemrattrakool, et al.
Published: (2025-01-01) -
Potential of emodepside for vector-borne disease control
by: Khemrattrakool, P, et al.
Published: (2025) -
Emodepside: the anthelmintic’s mode of action and toxicity
by: Charity N. Njeshi, et al.
Published: (2024-12-01)